Associated Papers
Allosteric modulation and G-protein selectivity of the Ca2+-sensing receptor.
He F et al.
Nature, 2024
Calcilytic NPSP795 Increases Plasma Calcium and PTH in an Autosomal Dominant Hypocalcemia Type 1 Mouse Model.
Hannan FM et al.
Jbmr Plus, 2020
Treatment of Autosomal Dominant Hypocalcemia Type 1 With the Calcilytic NPSP795 (SHP635).
Roberts MS et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2019
Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics.
Mayr B et al.
Trends in Endocrinology and Metabolism: Tem, 2016
Identification and dissection of Ca(2+)-binding sites in the extracellular domain of Ca(2+)-sensing receptor.
Huang Y et al.
The Journal of Biological Chemistry, 2007
Select a paper to view details